Correlation Between ABVC Biopharma and Adial Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ABVC Biopharma and Adial Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ABVC Biopharma and Adial Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ABVC Biopharma and Adial Pharmaceuticals, you can compare the effects of market volatilities on ABVC Biopharma and Adial Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ABVC Biopharma with a short position of Adial Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of ABVC Biopharma and Adial Pharmaceuticals.

Diversification Opportunities for ABVC Biopharma and Adial Pharmaceuticals

-0.68
  Correlation Coefficient

Excellent diversification

The 3 months correlation between ABVC and Adial is -0.68. Overlapping area represents the amount of risk that can be diversified away by holding ABVC Biopharma and Adial Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Adial Pharmaceuticals and ABVC Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ABVC Biopharma are associated (or correlated) with Adial Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Adial Pharmaceuticals has no effect on the direction of ABVC Biopharma i.e., ABVC Biopharma and Adial Pharmaceuticals go up and down completely randomly.

Pair Corralation between ABVC Biopharma and Adial Pharmaceuticals

Given the investment horizon of 90 days ABVC Biopharma is expected to generate 0.72 times more return on investment than Adial Pharmaceuticals. However, ABVC Biopharma is 1.38 times less risky than Adial Pharmaceuticals. It trades about 0.21 of its potential returns per unit of risk. Adial Pharmaceuticals is currently generating about 0.05 per unit of risk. If you would invest  106.00  in ABVC Biopharma on April 30, 2025 and sell it today you would earn a total of  196.00  from holding ABVC Biopharma or generate 184.91% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy98.39%
ValuesDaily Returns

ABVC Biopharma  vs.  Adial Pharmaceuticals

 Performance 
       Timeline  
ABVC Biopharma 

Risk-Adjusted Performance

Solid

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in ABVC Biopharma are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain basic indicators, ABVC Biopharma exhibited solid returns over the last few months and may actually be approaching a breakup point.
Adial Pharmaceuticals 

Risk-Adjusted Performance

Insignificant

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Adial Pharmaceuticals are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite quite uncertain forward indicators, Adial Pharmaceuticals disclosed solid returns over the last few months and may actually be approaching a breakup point.

ABVC Biopharma and Adial Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ABVC Biopharma and Adial Pharmaceuticals

The main advantage of trading using opposite ABVC Biopharma and Adial Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ABVC Biopharma position performs unexpectedly, Adial Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adial Pharmaceuticals will offset losses from the drop in Adial Pharmaceuticals' long position.
The idea behind ABVC Biopharma and Adial Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Other Complementary Tools

Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Transaction History
View history of all your transactions and understand their impact on performance
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Global Correlations
Find global opportunities by holding instruments from different markets